Ribavirin (State of Florida DOH Central Pharmacy)
Welcome to the PulseAid listing for the Ribavirin drug offered from State of Florida DOH Central Pharmacy. This Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | State of Florida DOH Central Pharmacy |
NON-PROPRIETARY NAME: | RIBAVIRIN |
SUBSTANCE NAME: | RIBAVIRIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Nucleoside Analog [Chemical/Ingredient],Nucleoside Analog Antiviral [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
Ribavirin HUMAN PRESCRIPTION DRUG Details:
Item Description | Ribavirin from State of Florida DOH Central Pharmacy |
LABELER NAME: | State of Florida DOH Central Pharmacy |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mg/1) |
START MARKETING DATE: | 2009-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 53808-0781_cbb7cff7-62dd-4bb5-aee5-4202eb730940 |
PRODUCT NDC: | 53808-0781 |
APPLICATION NUMBER: | ANDA076192 |
Other RIBAVIRIN Pharmaceutical Manufacturers / Labelers: